FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'

2.

Win for Perioperative Durvalumab in Muscle-Invasive Bladder Cancer

3.

Study finds 1 in 12 patients labeled as having 'benign' results actually had high-risk prostate cancer

4.

When does a melanoma metastasize? Implications for management

5.

The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot